Diagnostische marker in der Urologie

Hupe, M. C., Hempel, M. C., Rodler, S., Frantzi, M., Mischak, H., Merseburger, A. S., Stief, C. G. and Chaloupka, M. (2021) Diagnostische marker in der Urologie. Urologe, 60(10), pp. 1323-1330. (doi: 10.1007/s00120-021-01568-8) (PMID:34156515)

Full text not currently available from Enlighten.

Abstract

Cancer diagnostics can be supplemented by disease-related biomarkers. In the course of modern patient-tailored cancer treatment, the importance of correct risk stratification, prognosis and monitoring has significantly increased. In recent years, a multitude of biomarkers and related test procedures have emerged to fulfil this purpose. The following review article summarizes the most recent developments with respect to the use of biomarkers in the diagnostics of urological cancers.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mischak, Professor Harald
Authors: Hupe, M. C., Hempel, M. C., Rodler, S., Frantzi, M., Mischak, H., Merseburger, A. S., Stief, C. G., and Chaloupka, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Urologe
Publisher:Springer
ISSN:0340-2592
ISSN (Online):1433-0563
Published Online:22 June 2021

University Staff: Request a correction | Enlighten Editors: Update this record